The success of Biogen and Keryx are yet to be solidified, but the signs are looking good. Most US investors tend to overlook the biopharmaceutical industry, and now is the right time to get their attention. Investing on companies like Biogen and Keryx during this time is may be foolproof. Biogen is one of the industry's best performers while Keryx is on the rise to compete with big names without too much risk through creating profitable partnerships.
 The Full Research Report on Biogen Idec Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.nationaltradersassociation.org/r/entire_report/37fb_BIIB ]
[ 2 ] The Free Research Report on Keryx Biopharmaceuticals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.nationaltradersassociation.org/r/entire_report/7972_KERX ]Consider National Traders Association Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop -- long before they become the next top news on major financial networks. Contact: Demi Lapierre Email: press@NationalTradersAssociation.org Main: +1-(702)-212-4493 SOURCE National Traders Association